Anti-p53 (acetyl K382) antibody [EPR358(2)]

• Supplier: Abcam
• Catalog: ab75754
• Prices: $395.00
• Sizes: 100 µl
• Host: Rabbit
• Clonality: Monoclonal
• Isotype: IgG
• Clone: EPR358(2)
• Applications: WB ICC/IF
• Species Reactivities: Human
• Antigen: A synthetic acetylated peptide corresponding to residues surrounding K382 of human p53
• Blocking Peptide: p53 (acetyl K382) peptide
• Description: Rabbit Monoclonal
• Gene: TP53
• Conjugate: Unconjugated

Product images

All lanes : Anti-p53 (acetyl K382) antibody [EPR358(2)] (ab75754) at 1/5000 dilutionLane 1 : HepG2 cell lysates un-treatedLane 2 : HepG2 cell lysates treated with etopside and TSALysates/proteins at 10 µg per lane.SecondaryHRP labelled goat anti-rabbit at 1/2000 dilution

Product References

Identification of LDH-A as a therapeutic target for cancer cell killing via (i) - Identification of LDH-A as a therapeutic target for cancer cell killing via (i)

Allison SJ, Knight JR, Granchi C, Rani R, Minutolo F, Milner J, Phillips RM. Oncogenesis. 2014 May 12;3:e102.

Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and - Human cytomegalovirus pUL29/28 and pUL38 repression of p53-regulated p21CIP1 and

Savaryn JP, Reitsma JM, Bigley TM, Halligan BD, Qian Z, Yu D, Terhune SS. J Virol. 2013 Mar;87(5):2463-74.

Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1 - Active regulator of SIRT1 is required for cancer cell survival but not for SIRT1

Knight JR, Allison SJ, Milner J. Open Biol. 2013 Nov 20;3(11):130130.

Aurora A mediates cross-talk between N- and C-terminal post-translational - Aurora A mediates cross-talk between N- and C-terminal post-translational

Warnock LJ, Raines SA, Milner J. Cancer Biol Ther. 2011 Dec 15;12(12):1059-68.

DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of - DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of

Guo X, Williams JG, Schug TT, Li X. J Biol Chem. 2010 Apr 23;285(17):13223-32.